Companies/SE/NXTCL

NEXTCELL PHARMA AB

Last · StockholmSEK 0.993+0.011 (+1.12%)live · yahoo · 56m ago
Vol 9.5K ≈ 9.5K
Market capSEK 125.5M126.4M sh
P/E · TTM-2.3fwd — · eps -0.43 · loss
Beta0.68vs S&P 500
Div yield0.00%annual · TTM
52w range
SEK 0.63SEK 1.784
Volume9.5Ksession

Issuer

Legal nameNEXTCELL PHARMA AB
HQSweden (SE)
ListingSE NXTCL
ISINSE0009723125
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencySEK
Entity registryisin:SE0009723125
Org IDNXTCL
Websitewww.nextcellpharma.com
Employees24
AddressNextCell Pharma AB Hälsovägen 7 141 57, Huddinge
Headline financial metrics
RevenueSEK 13.7M
Operating incomeSEK -51.8M
Net incomeSEK -50.9M
Free cash flowSEK -55.9M
Operating margin-378.2%
Net margin-371.8%
Return on equity-100.7%
Period2025
Loading chart…

Documents

FormReporting forFiledFlags
proxyPower of Attorney Form Annual General Meeting 2026IR
—2026-12-31≈0
proxyNotice to Annual Meeting 2026IR
—2026-12-31≈0
interim report2026-05-28 Interim Report Q1 2026IR
—2026-08-270
interim report2026-08-27 Interim Report Q2 2026IR
—2026-08-270
ANNUAL
2025-12-312026-05-040
Showing 5 of 102 filings